Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles
Abstract Background p53 is a tumor suppressor and key regulator of glycolysis in cancer cells, however highly mutated in tumors. In ovarian cancer, studies concerning p53 mutations focus on the DNA binding domain since the majority of hotspot mutations affects this region. Yet, mutations in other re...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-018-0514-2 |
_version_ | 1818543368087535616 |
---|---|
author | Stephanie Antoun David Atallah Roula Tahtouh Nada Alaaeddine Malak Moubarak Abir Khaddage Eliane Nasr Ayoub George Chahine George Hilal |
author_facet | Stephanie Antoun David Atallah Roula Tahtouh Nada Alaaeddine Malak Moubarak Abir Khaddage Eliane Nasr Ayoub George Chahine George Hilal |
author_sort | Stephanie Antoun |
collection | DOAJ |
description | Abstract Background p53 is a tumor suppressor and key regulator of glycolysis in cancer cells, however highly mutated in tumors. In ovarian cancer, studies concerning p53 mutations focus on the DNA binding domain since the majority of hotspot mutations affects this region. Yet, mutations in other regions such as the proline rich domain may also affect the protein’s expression and activity. The aim of this study is to investigate the effect of various positions of mutations in TP53 gene on glycolysis, apoptosis and transcription of p53 target genes. Methods Mutations frequency and their effect on p53 expression were assessed by PCR-SSCP, sequencing and immunohistochemistry on 30 ovarian cancer biopsies. Six tumors were cultured, as well as SK-OV-3, OVCAR-3 and Igrov-1. SK-OV-3 cells were transfected with 2 TP53 mutants. p53 transcriptional activity was assayed by qPCR, apoptosis by flow cytometry and glycolysis by glucose and lactate measurements, with quantification of glycolytic enzymes expression. Results Our results showed a high frequency of the P72R mutant, associated with p53 overexpression in the ovarian biopsies. However, P72R mutant cells showed similar apoptosis and glycolysis as WT cells. DNA binding domain mutations decreased the transcriptional activity of the protein and increased glucose consumption and lactate production. Conclusion Despite the overexpression of the P72R mutated protein in the biopsies, it showed a similar apoptotic activity and glucose regulation ability as WT p53. Knowing that p53 expression status is used for chemotherapeutic approaches and prognosis in ovarian cancer, the results obtained highlight the importance of locating TP53 mutations. |
first_indexed | 2024-12-11T22:34:27Z |
format | Article |
id | doaj.art-00521658b23741eca70c31bb9bbcae0f |
institution | Directory Open Access Journal |
issn | 1475-2867 |
language | English |
last_indexed | 2024-12-11T22:34:27Z |
publishDate | 2018-01-01 |
publisher | BMC |
record_format | Article |
series | Cancer Cell International |
spelling | doaj.art-00521658b23741eca70c31bb9bbcae0f2022-12-22T00:48:02ZengBMCCancer Cell International1475-28672018-01-0118111010.1186/s12935-018-0514-2Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profilesStephanie Antoun0David Atallah1Roula Tahtouh2Nada Alaaeddine3Malak Moubarak4Abir Khaddage5Eliane Nasr Ayoub6George Chahine7George Hilal8Cancer and Metabolism Laboratory, Faculty of Medicine, Saint Joseph UniversityObstetrics and Gynecology Department, Hotel-Dieu De France HospitalCancer and Metabolism Laboratory, Faculty of Medicine, Saint Joseph UniversityRegenerative Medicine and Inflammation Laboratory, Faculty of Medicine, Saint Joseph UniversityObstetrics and Gynecology Department, Hotel-Dieu De France HospitalAnatomy and Pathology Department, Hotel-Dieu De France HospitalAnesthesiology Department, Hotel-Dieu De France HospitalOncology Department, Hotel-Dieu De France HospitalCancer and Metabolism Laboratory, Faculty of Medicine, Saint Joseph UniversityAbstract Background p53 is a tumor suppressor and key regulator of glycolysis in cancer cells, however highly mutated in tumors. In ovarian cancer, studies concerning p53 mutations focus on the DNA binding domain since the majority of hotspot mutations affects this region. Yet, mutations in other regions such as the proline rich domain may also affect the protein’s expression and activity. The aim of this study is to investigate the effect of various positions of mutations in TP53 gene on glycolysis, apoptosis and transcription of p53 target genes. Methods Mutations frequency and their effect on p53 expression were assessed by PCR-SSCP, sequencing and immunohistochemistry on 30 ovarian cancer biopsies. Six tumors were cultured, as well as SK-OV-3, OVCAR-3 and Igrov-1. SK-OV-3 cells were transfected with 2 TP53 mutants. p53 transcriptional activity was assayed by qPCR, apoptosis by flow cytometry and glycolysis by glucose and lactate measurements, with quantification of glycolytic enzymes expression. Results Our results showed a high frequency of the P72R mutant, associated with p53 overexpression in the ovarian biopsies. However, P72R mutant cells showed similar apoptosis and glycolysis as WT cells. DNA binding domain mutations decreased the transcriptional activity of the protein and increased glucose consumption and lactate production. Conclusion Despite the overexpression of the P72R mutated protein in the biopsies, it showed a similar apoptotic activity and glucose regulation ability as WT p53. Knowing that p53 expression status is used for chemotherapeutic approaches and prognosis in ovarian cancer, the results obtained highlight the importance of locating TP53 mutations.http://link.springer.com/article/10.1186/s12935-018-0514-2ApoptosisGlucose metabolismMutationp53 overexpressionOvarian cancer |
spellingShingle | Stephanie Antoun David Atallah Roula Tahtouh Nada Alaaeddine Malak Moubarak Abir Khaddage Eliane Nasr Ayoub George Chahine George Hilal Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles Cancer Cell International Apoptosis Glucose metabolism Mutation p53 overexpression Ovarian cancer |
title | Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles |
title_full | Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles |
title_fullStr | Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles |
title_full_unstemmed | Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles |
title_short | Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles |
title_sort | different tp53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles |
topic | Apoptosis Glucose metabolism Mutation p53 overexpression Ovarian cancer |
url | http://link.springer.com/article/10.1186/s12935-018-0514-2 |
work_keys_str_mv | AT stephanieantoun differenttp53mutantsinp53overexpressedepithelialovariancarcinomacanbeassociatedbothwithalteredandunalteredglycolyticandapoptoticprofiles AT davidatallah differenttp53mutantsinp53overexpressedepithelialovariancarcinomacanbeassociatedbothwithalteredandunalteredglycolyticandapoptoticprofiles AT roulatahtouh differenttp53mutantsinp53overexpressedepithelialovariancarcinomacanbeassociatedbothwithalteredandunalteredglycolyticandapoptoticprofiles AT nadaalaaeddine differenttp53mutantsinp53overexpressedepithelialovariancarcinomacanbeassociatedbothwithalteredandunalteredglycolyticandapoptoticprofiles AT malakmoubarak differenttp53mutantsinp53overexpressedepithelialovariancarcinomacanbeassociatedbothwithalteredandunalteredglycolyticandapoptoticprofiles AT abirkhaddage differenttp53mutantsinp53overexpressedepithelialovariancarcinomacanbeassociatedbothwithalteredandunalteredglycolyticandapoptoticprofiles AT elianenasrayoub differenttp53mutantsinp53overexpressedepithelialovariancarcinomacanbeassociatedbothwithalteredandunalteredglycolyticandapoptoticprofiles AT georgechahine differenttp53mutantsinp53overexpressedepithelialovariancarcinomacanbeassociatedbothwithalteredandunalteredglycolyticandapoptoticprofiles AT georgehilal differenttp53mutantsinp53overexpressedepithelialovariancarcinomacanbeassociatedbothwithalteredandunalteredglycolyticandapoptoticprofiles |